KPV

Price range: $69.99 through $209.97

Bundle & save

Sale!

COAs

KPV

Price range: $69.99 through $209.97

Bundle & save

KPV (Lys–Pro–Val) is the C-terminal tripeptide fragment of α-melanocyte stimulating hormone (α-MSH). As a small, bioactive peptide, KPV reproduces many of α-MSH’s multiple activities while avoiding full-length melanocortin receptor signaling in some contexts.

Description

KPV (Lys–Pro–Val) is the C-terminal tripeptide fragment of α-melanocyte stimulating hormone (α-MSH). As a small, bioactive peptide, KPV reproduces many of α-MSH’s activities while avoiding full-length melanocortin receptor signaling in some contexts.

The KPV peptide sequence is a useful research tool for studying multiple peptide mechanisms.

Properties of TB-500

  • Peptide Sequence: Lys-Pro-Val (H-Lys-Pro-Val-OH)
  • Molecular Formula: C16H30N4O4
  • Molecular Weight: 342.43 g/mol
  • CAS Number: 67727-97-3
  • PubChem CID: 125672
  • Synonyms: α-MSH(11-13), ACTH(11-13), MSH(11-13)

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Additional information

Size

1 Vial (10mg), 3 + 1 Free

Research Overview

KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH, positions 11-13) that has been studied in laboratory settings. Research demonstrates KPV operates through melanocortin receptor-independent pathways, making it distinct from its parent molecule.

Molecular Mechanisms

KPV enters cells via the PepT1 oligopeptide transporter with high affinity (Km ~160 μM in Caco2 cells). Studies show the peptide accumulates in the nucleus within 5 hours, where it competitively disrupts the interaction between p65RelA and importin-α3, blocking NFκB nuclear translocation.[1]

At nanomolar concentrations (10 nM), KPV also suppresses all three major MAPK subfamilies (ERK1/2, JNK, p38) in intestinal epithelial cells. This mechanism occurs independently of melanocortin receptors and reduces inflammatory cytokine expression.[2]

Gastrointestinal Inflammation Models

Oral KPV administration in murine DSS and TNBS colitis models demonstrated significant reductions in:

  • Colonic myeloperoxidase activity (~50% decrease, p<0.05)
  • Pro-inflammatory cytokine mRNA (IL-6, IL-12, TNF-α, IFN-γ)
  • Epithelial damage and cell infiltration

Research indicates KPV’s efficacy correlates with PepT1 expression, which becomes upregulated during IBD.[1]

Airway and Pulmonary Studies

In bronchial epithelial cells (16HBE14o-), KPV reduced TNFα-induced responses:

  • NFκB reporter activity decreased at concentrations ≥1 μg/ml
  • IL-8 mRNA reduced by ~35% (p<0.05)
  • MMP-9 gelatinolytic activity returned to baseline levels
  • Eotaxin secretion significantly attenuated

These findings suggest potential applications in research models.[2]

Immune Cell Modulation

Human Jurkat T cells and immune populations express functional PepT1, enabling KPV uptake. Studies demonstrate that 10 nM KPV stabilizes IκBα protein levels and reduces IL-8 transcription by ~40% following TNFα stimulation.

During certain conditions, PepT1 expression increases in lamina propria macrophages and peripheral T cells, providing delivery pathways for peptide-based research tools.[1]

Dermatological Research

KPV retains activity without activating MC1R, the melanogenesis receptor. This property makes it useful for research where pigmentation effects would confound results.[3]

Stereoisomers like KdPT (Lys-D-Pro-Thr) show enhanced proteolytic stability. Research on sebocytes demonstrated KdPT suppresses IL-1β-mediated cytokine signaling, relevant to acne pathogenesis studies.

Structure-Activity Relationships

The tripeptide KPV represents the minimal α-MSH sequence retaining activity. Deletion studies confirm truncation beyond KPV eliminates efficacy.[4]

D-amino acid substitutions (KdPV, KPdV, dKPV) preserve activity while enhancing proteolytic resistance. Glycoalkylation of the lysine residue increases stability but eliminates certain properties, demonstrating structure-dependent bioactivity profiles.[5]

Research Use Only: KPV is intended for in vitro laboratory research and experimental protocols. All findings referenced represent preclinical research models and are not validated for therapeutic applications.

References

  1. Dalmasso G, Charrier–Hisamuddin L, Thu Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Elsevier BV; 2008. https://doi.org/10.1053/j.gastro.2007.10.026
  2. Land S. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. International Journal of Physiology, Pathophysiology and Pharmacology. 2012;4(2):59–73.
  3. Böhm M, Luger T. Are melanocortin peptides future therapeutics for cutaneous wound healing? Wiley; 2019. https://doi.org/10.1111/exd.13887
  4. Luger TA, Brzoska T. α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Elsevier BV; 2007. https://doi.org/10.1136/ard.2007.079780
  5. Songok AC, Panta P, Doerrler WT, Macnaughtan MA, Taylor CM. Structural modification of the tripeptide KPV by reductive “glycoalkylation” of the lysine residue. Public Library of Science (PLoS); 2018. https://doi.org/10.1371/journal.pone.0199686

Peptide Catalog

Peptide Capsule

NovaZapetite
NovaGutPro
ShredMAX
NovaCartilage (A-4)
NovaLiver (A-7) NovaLiver

(A-7) NovaKidney (A-9) NovaKidney (A-9) NovaPineal (A-8) NovaPineal (A-8) NovaRetina (A-11) NovaRetina (A-11) NovaProstate (A-16) NovaProstate (A-16)

Be the first to know

Receive the latest updates on Peptide Research new products and upcoming sales

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare